info@ease-med-control.com
News
2019
December 11th
Easemedcontrol scientist Changjun Yin receives 50000.- € from the Excellent program of the Ludwig-Maximilians-University Munich (LMU) to support his application for an European Research Council Starting Grant in 2020
2019
January 28th
Easemedcontrol scientists publish a landmark study in Nature Medicine on atherosclerosis and Alzheimer´s Disease (see https://www.nature.com/articles/s41591-018-0336-8)
2019
February 28th
Easemedcontrol founder Changjun Yin receives the prestigious Bayer Research Award 2019; see press releases here:
The jury states
“The jury believes that your innovative work may become very important for new treatment strategies in Atherosclerosis and Alzheimer’s diseases since both are prototypical unresolvable inflammatory diseases with high risks to develop thrombosis-related diseases and your work has shown that anti-complement C5 therapy can reduce such thrombotic events in patients afflicted with complement-triggered diseases. Recent research indicates that oxidized lipids from diseased arteries or Aβ plaques in the brain trigger both the complement and coagulation cascades. A better understanding of the regulation of complement cascades in chronic inflammation may therefore facilitate the development of novel therapies for patients with thrombotic conditions, i.e. atherosclerosis and AD.”
2019
March 25-26
Saroj Mohanta and Andreas Habenicht attend an annual meeting of the European Research Arena Cardiovascular Disease consortium (ERA-CVD; of 6 European research partners; coordinated by Andreas Habenicht) in Pozzilli Italy to report on their discovery of an atherosclerosis-brain-circuit.
ERA-Net on Cardiovascular Diseases (ERA-CVD) PLAQUEFIGHT and NEMO-IMMUNEagainstHF Joint Meeting March 25th to 26th, 2019
Venue: IRCCS Neuromed Technology Park
Via dell’Elettronica, Località Camerelle – 86077 Pozzilli (IS), Italy
2019
May 14-16
Andreas Habenicht and Sarajo Mohanta report on the progress of the European research arena (ERA-CVD) consortium in Riga Latvia
Saraj Mohanta received the first poster award see https://www.era-cvd.eu/400.php
2019
June 25th
Easemedcontrol scientists Changjun Yin and Andreas Habenicht receive 578 000.- € from the German Research Council to study B-cell autoimmunity in atherosclerosis for 3 years
